BSE filing, NSE: KAKTEX. Summary written from the filing by ALFA Finder's alert engine.
Kakatiya Textiles Ltd: key numbers
- Share price
- ₹9.50
- Market cap
- ₹5.52 Cr
- Revenue (annual)
- ₹31.45 Cr
- Net profit (annual)
- ₹-5.02 Cr
- P/E (TTM)
- -1.2×Sector 49.0×
- Promoter holding
- 51.03%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kakatiya Textiles Ltd
All →Kakatiya Textiles Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory disclosure of its shareholding structure.
Kakatiya Textiles Annual General Meeting
Kakatiya Textiles Ltd held its 44th Annual General Meeting, transacting routine business including the adoption of financial statements and re-appointment of a director.
Kakatiya Textiles Annual General Meeting
Kakatiya Textiles Limited has issued a notice for its 44th Annual General Meeting, scheduled for September 29, 2026. The company also submitted its Annual Report.
Kakatiya Textiles Q1 FY27 Results: Net Loss of ₹0.2 Cr, Loss Narrows
Kakatiya Textiles Ltd reported revenue from operations of ₹11.8 Cr (+68.6% YoY) and a net loss of ₹0.2 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.2 Cr
Kakatiya Textiles Q4 FY26 Results: Net Loss of ₹1.6 Cr
Kakatiya Textiles Ltd reported revenue from operations of ₹12 Cr (-47.1% YoY) and a net loss of ₹1.6 Cr for Q4 FY26.
- Key figure
- Net loss ₹1.6 Cr
Kakatiya Textiles Financial Results
Kakatiya Textiles reported audited FY26 results with total income of ₹31.52 Crore and a net loss of ₹5.02 Crore. Exceptional items include machinery sale profits.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.